Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.

Access to medicines faces a new legal threat: "border enforcement" of drug patents. Using Brazil as an example, this article shows how the right to health depends on international trade. Border seizures of generic drugs present human rights and trade institutions with a unique challenge. Can public health advocates rise to meet it?
AuthorsMônica Steffen Guise Rosina, Lea Shaver
JournalThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (J Law Med Ethics) Vol. 40 Issue 2 Pg. 197-205 ( 2012) ISSN: 1748-720X [Electronic] England
PMID22789040 (Publication Type: Journal Article)
Copyright© 2012 American Society of Law, Medicine & Ethics, Inc.
Chemical References
  • Drugs, Generic
  • Brazil
  • Commerce (legislation & jurisprudence)
  • Developing Countries
  • Drug Industry (ethics, legislation & jurisprudence)
  • Drugs, Generic (supply & distribution)
  • European Union
  • Health Services Accessibility
  • Human Rights
  • Humans
  • International Cooperation
  • Law Enforcement
  • Patents as Topic (ethics, legislation & jurisprudence)
  • Patient Rights (ethics, legislation & jurisprudence)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: